NDC 60681-1086

Pleo Chrys

Human Placenta Hydrolysate

Pleo Chrys is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Sanum Kehlbeck Gmbh & Co. Kg. The primary component is Human Placenta Hydrolysate.

• Product ID: 60681-1086_cbf8a5ca-4a01-4d24-8224-822f91db8de6
• NDC: 60681-1086
• Product Type: Human Otc Drug
• Proprietary Name: Pleo Chrys
• Generic Name: Human Placenta Hydrolysate
• Dosage Form: Liquid
• Route of Administration: ORAL
• Marketing Start Date: 2004-10-15
• Marketing Category: UNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
• Labeler Name: Sanum Kehlbeck GmbH & Co. KG
• Substance Name: HUMAN PLACENTA HYDROLYSATE
• Active Ingredient Strength: 5 [hp_X]/2mL
• NDC Exclude Flag: E
• Listing Certified Through: 2017-12-31

Packaging

NDC 60681-1086-1

10 VIAL, GLASS in 1 CARTON (60681-1086-1) > 2 mL in 1 VIAL, GLASS

• Marketing Start Date: 2004-10-15
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 60681-1086-2 [60681108602]

Pleo Chrys LIQUID

• Marketing Category: UNAPPROVED HOMEOPATHIC
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 2004-10-15
• Inactivation Date: 2019-11-13

NDC 60681-1086-1 [60681108601]

Pleo Chrys LIQUID

• Marketing Category: UNAPPROVED HOMEOPATHIC
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 2004-10-15
• Inactivation Date: 2019-11-13

Drug Details

Active Ingredients

Ingredient	Strength
HUMAN PLACENTA HYDROLYSATE	5 [hp_X]/2mL

OpenFDA Data

• SPL SET ID: 506c98ed-69ec-418f-b659-46fa47535521
• Manufacturer:
  • Sanum Kehlbeck GmbH & Co. KG
• UNII:
  • 24L835P10X